BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32964615)

  • 1. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
    van Dijk M; Drenth JPH;
    J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study.
    van Dijk M; Boyd A; Brakenhoff SM; Isfordink CJ; van Zoest RA; Verhagen MD; de Knegt RJ; Drenth JPH; van der Valk M;
    Liver Int; 2024 Jan; 44(1):52-60. PubMed ID: 37718515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.
    Isfordink CJ; Brakenhoff SM; van Dijk M; van der Valk M; de Knegt RJ; Arends JE; Drenth JP;
    BMJ Open Gastroenterol; 2020; 7(1):e000396. PubMed ID: 32377367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea.
    Ghebremeskel GG; Berhe Solomon M; Achila OO; Mengistu ST; Asmelash RF; Berhane Mesfin A; Hamida ME
    Sci Rep; 2023 Nov; 13(1):20792. PubMed ID: 38012181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV survey.
    Lin TY; Jen HH; Hu TH; Yao YC; Chen TH; Yen AM; Yeh YP
    Hepatol Int; 2024 Apr; 18(2):476-485. PubMed ID: 37987951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination.
    Taye BW
    Am J Trop Med Hyg; 2019 Nov; 101(5):963-972. PubMed ID: 31516107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience.
    Torre P; Coppola R; Masarone M; Persico M
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'We've got a present for you': Hepatitis C elimination, compromised healthcare subjects and treatment as a gift.
    Farrugia A; Lenton E; Seear K; Kagan D; Valentine K; Fraser S; Mulcahy S; Edwards M; Jeffcote D
    Soc Sci Med; 2024 Jan; 340():116416. PubMed ID: 38039771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward antivirals against hepatitis E: In the steps of hepatitis C.
    Gouttenoire J; Neyts J
    Hepatology; 2023 Dec; 78(6):1695-1697. PubMed ID: 37300387
    [No Abstract]   [Full Text] [Related]  

  • 10. The path to successful hepatitis C elimination in Spain.
    Crespo J; Cabezas J; Calleja JL; Buti M; Lazarus JV
    Nat Rev Gastroenterol Hepatol; 2023 Nov; 20(11):689-690. PubMed ID: 37500899
    [No Abstract]   [Full Text] [Related]  

  • 11. 'There's too much power in this number. It's freaking the whole response out': The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia.
    Treloar C; Rance J; Bryant J; Lafferty L
    J Viral Hepat; 2024 Feb; 31(2):59-65. PubMed ID: 37916576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US Hepatitis C Elimination Plan.
    Berk J; Litwin A; Murphy M
    JAMA; 2023 Sep; 330(9):877-878. PubMed ID: 37668627
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C: Egypt makes "unprecedented progress" towards elimination.
    Mahase E
    BMJ; 2023 Oct; 383():2353. PubMed ID: 37816531
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward the hepatitis C virus elimination in Asia: The policy forum from the 2023 Asian Pacific Association of the Study of the Liver (APASL).
    Liu CH; Lin HC; Kao JH
    J Formos Med Assoc; 2023 Dec; 122(12):1234-1237. PubMed ID: 37821301
    [No Abstract]   [Full Text] [Related]  

  • 15. Joint statement in support of hepatitis C human challenge studies.
    Alter HJ; Barnes E; Biondi MJ; Cox AL; Eberts JD; Feld JJ; Liang TJ; Morrison J; Rice CM; Shoukry NH; Thomas DL; Van Gennip J; Weijer C;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):967-969. PubMed ID: 37742699
    [No Abstract]   [Full Text] [Related]  

  • 16. A square peg in a round hole: treating hepatitis C.
    Bailey E; Bailey A
    Am J Manag Care; 2023 Nov; 29(11):e320-e321. PubMed ID: 37948651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Elimination of Chronic Hepatitis.
    Renelus BD; Jamorabo DS; Mohanty SR
    N Engl J Med; 2019 Aug; 381(6):589-590. PubMed ID: 31390515
    [No Abstract]   [Full Text] [Related]  

  • 18. Global Elimination of Chronic Hepatitis.
    Bsisu I; Rmilah AA
    N Engl J Med; 2019 Aug; 381(6):589. PubMed ID: 31390514
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?
    Prabhakar V; Kwo PY
    Hepatol Commun; 2019 Sep; 3(9):1174-1176. PubMed ID: 31497738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care.
    Kushner T; Terrault NA
    Hepatol Commun; 2019 Jan; 3(1):20-28. PubMed ID: 30619991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.